Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 2 mL Single-Dose Vial, Rx Only, Distributed by: Areva Pharmaceuticals, Inc., Gerogetown, IN 47122, Made in India, NDC 59923-714-02.
Published March 3, 2021 · Recall initiated: November 19, 2020
Summary
FDA records drug Class II recall D-0270-2021, published March 3, 2021 and initiated November 19, 2020. Recalling firm: Areva Pharmaceuticals Inc; Status: Terminated; Reported quantity: 3287 vials; Lot: Lot 7S10022A, Exp Jan-21. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: based on a Warning Letter received by the manufacturer of the recalled product for inadequate out-of specification investigations, complaint and the investigation conclusions.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Areva Pharmaceuticals Inc
- Distributor
- Nationwide in the USA
- Lot
- Lot 7S10022A, Exp Jan-21
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAManukaGuard Medical Grade Manuka Honey Allercleanse Nasal Spray, 1.3 FL OZ (40mL) bottle, 270 measured sprays,March 3, 2021
- FDADacarbazine for Injection USP, 200 mg, Single Use Vial (NDC 0703-5075-01), packaged in 10X20 ML Single UseMarch 3, 2021
- FDABD ChloraPrep Hi-Lite Orange 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), SterileMarch 3, 2021
- FDADesmopressin Acetate Injection USP, 4 mcg/mL, 1 mL Preserved Vial (NDC 0703-5051-01), packaged in 10X1 mLMarch 3, 2021
- FDAChloraPrep One-Step 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Non-SterileMarch 3, 2021
- FDASterile Diluent for Epoprostenol Sodium for Injection, 50 mL vial (NDC 0703-9258-01), packaged in 2X50ML perMarch 3, 2021
Questions about this recall
Was Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 2 mL Single-Dose Vial, Rx Only, Distributed by: Areva Pharmaceuticals, Inc., Gerogetown, IN 47122, Made in India, NDC 59923-714-02. recalled?
Yes. FDA published recall D-0270-2021 on March 3, 2021. Reported hazard: CGMP Deviations: based on a Warning Letter received by the manufacturer of the recalled product for inadequate out-of specification investigations, complaint and the investigation conclusions.
What should I do if I have this product?
Voluntary: Firm initiated · Letter